Dr. Hofmeister on the Treatment of Patients with Newly Diagnosed Myeloma

Craig Hofmeister, MD
Published: Tuesday, Oct 03, 2017



Craig Hofmeister, MD, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the treatment of patients with newly diagnosed multiple myeloma.

Patients with multiple myeloma who are fit are usually able to treated with any available agent, says Hofmeister.

The most effective treatment is usually a 3-drug therapy of an immunomodulatory drug, a protostome inhibitor, and dexamethasone, Hofmeister adds.
 


Craig Hofmeister, MD, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the treatment of patients with newly diagnosed multiple myeloma.

Patients with multiple myeloma who are fit are usually able to treated with any available agent, says Hofmeister.

The most effective treatment is usually a 3-drug therapy of an immunomodulatory drug, a protostome inhibitor, and dexamethasone, Hofmeister adds.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x